These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structural Assessment of Roe SK; Zhu T; Slepenkin A; Berges A; Fairman J; de la Maza LM; Massari P Vaccines (Basel); 2024 Jul; 12(7):. PubMed ID: 39066427 [No Abstract] [Full Text] [Related]
3. Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis. Su H; Morrison RP; Watkins NG; Caldwell HD J Exp Med; 1990 Jul; 172(1):203-12. PubMed ID: 1694217 [TBL] [Abstract][Full Text] [Related]
4. Protection against a chlamydial respiratory challenge by a chimeric vaccine formulated with the Tifrea DF; Pal S; Fairman J; Massari P; de la Maza LM NPJ Vaccines; 2020; 5(1):37. PubMed ID: 32411400 [No Abstract] [Full Text] [Related]
5. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen. Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice. Zhu S; Feng Y; Rao P; Xue X; Chen S; Li W; Zhu G; Zhang L Appl Microbiol Biotechnol; 2014 May; 98(9):4107-17. PubMed ID: 24458565 [TBL] [Abstract][Full Text] [Related]
8. Spectroscopic analysis of chlamydial major outer membrane protein in support of structure elucidation. Hepler RW; Nahas DD; Lucas B; Kaufhold R; Flynn JA; Galli JD; Swoyer R; Wagner JM; Espeseth AS; Joyce JG; Cook JC; Durr E Protein Sci; 2018 Nov; 27(11):1923-1941. PubMed ID: 30144190 [TBL] [Abstract][Full Text] [Related]
9. Induction of HLA class I-restricted CD8+ CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections. Kim SK; Angevine M; Demick K; Ortiz L; Rudersdorf R; Watkins D; DeMars R J Immunol; 1999 Jun; 162(11):6855-66. PubMed ID: 10352308 [TBL] [Abstract][Full Text] [Related]
10. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate. Campos M; Pal S; O'Brien TP; Taylor HR; Prendergast RA; Whittum-Hudson JA Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1477-91. PubMed ID: 7601629 [TBL] [Abstract][Full Text] [Related]
11. Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1. Xu W; Liu J; Gong W; Chen J; Zhu S; Zhang L Vaccine; 2011 Mar; 29(15):2672-8. PubMed ID: 21324344 [TBL] [Abstract][Full Text] [Related]
12. Unusual Self-Assembly of the Recombinant Chlamydia trachomatis Major Outer Membrane Protein-Based Fusion Antigen CTH522 Into Protein Nanoparticles. Rose F; Karlsen K; Jensen PR; Jakobsen RU; Wood GK; Rand KD; Godiksen H; Andersen P; Follmann F; Foged C J Pharm Sci; 2018 Jun; 107(6):1690-1700. PubMed ID: 29452143 [TBL] [Abstract][Full Text] [Related]
13. DNA plasmid vaccine carrying Chlamydia trachomatis (Ct) major outer membrane and human papillomavirus 16L2 proteins for anti-Ct infection. Wang L; Cai Y; Xiong Y; Du W; Cen D; Zhang C; Song Y; Zhu S; Xue X; Zhang L Oncotarget; 2017 May; 8(20):33241-33251. PubMed ID: 28402260 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model. Jiang P; Cai Y; Chen J; Ye X; Mao S; Zhu S; Xue X; Chen S; Zhang L Vaccine; 2017 May; 35(23):3096-3103. PubMed ID: 28456528 [TBL] [Abstract][Full Text] [Related]
15. Characterization and functional analysis of PorB, a Chlamydia porin and neutralizing target. Kubo A; Stephens RS Mol Microbiol; 2000 Nov; 38(4):772-80. PubMed ID: 11115112 [TBL] [Abstract][Full Text] [Related]
16. Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research. Wen Z; Boddicker MA; Kaufhold RM; Khandelwal P; Durr E; Qiu P; Lucas BJ; Nahas DD; Cook JC; Touch S; Skinner JM; Espeseth AS; Przysiecki CT; Zhang L BMC Microbiol; 2016 Jul; 16(1):165. PubMed ID: 27464881 [TBL] [Abstract][Full Text] [Related]
17. Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Baehr W; Zhang YX; Joseph T; Su H; Nano FE; Everett KD; Caldwell HD Proc Natl Acad Sci U S A; 1988 Jun; 85(11):4000-4. PubMed ID: 2453883 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine. Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158 [TBL] [Abstract][Full Text] [Related]
19. Antigenic specificity of a monovalent versus polyvalent MOMP based Chlamydia pecorum vaccine in koalas (Phascolarctos cinereus). Kollipara A; Wan C; Rawlinson G; Brumm J; Nilsson K; Polkinghorne A; Beagley K; Timms P Vaccine; 2013 Feb; 31(8):1217-23. PubMed ID: 23306372 [TBL] [Abstract][Full Text] [Related]
20. Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance. Desclozeaux M; Robbins A; Jelocnik M; Khan SA; Hanger J; Gerdts V; Potter A; Polkinghorne A; Timms P PLoS One; 2017; 12(6):e0178786. PubMed ID: 28575080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]